First Time Loading...

Bio Rad Laboratories Inc
NYSE:BIO

Watchlist Manager
Bio Rad Laboratories Inc Logo
Bio Rad Laboratories Inc
NYSE:BIO
Watchlist
Price: 279.83 USD 0.19% Market Closed
Updated: May 5, 2024

Bio Rad Laboratories Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bio Rad Laboratories Inc
Operating Income Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Bio Rad Laboratories Inc
NYSE:BIO
Operating Income
$365.7m
CAGR 3-Years
-5%
CAGR 5-Years
13%
CAGR 10-Years
8%
Thermo Fisher Scientific Inc
NYSE:TMO
Operating Income
$7.3B
CAGR 3-Years
-2%
CAGR 5-Years
14%
CAGR 10-Years
15%
Danaher Corp
NYSE:DHR
Operating Income
$9.5B
CAGR 3-Years
20%
CAGR 5-Years
26%
CAGR 10-Years
12%
Mettler-Toledo International Inc
NYSE:MTD
Operating Income
$1.1B
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
9%
Agilent Technologies Inc
NYSE:A
Operating Income
$1.3B
CAGR 3-Years
11%
CAGR 5-Years
6%
CAGR 10-Years
16%
IQVIA Holdings Inc
NYSE:IQV
Operating Income
$2.1B
CAGR 3-Years
38%
CAGR 5-Years
21%
CAGR 10-Years
16%

See Also

What is Bio Rad Laboratories Inc's Operating Income?
Operating Income
365.7m USD

Based on the financial report for Dec 31, 2023, Bio Rad Laboratories Inc's Operating Income amounts to 365.7m USD.

What is Bio Rad Laboratories Inc's Operating Income growth rate?
Operating Income CAGR 10Y
8%

Over the last year, the Operating Income growth was -25%. The average annual Operating Income growth rates for Bio Rad Laboratories Inc have been -5% over the past three years , 13% over the past five years , and 8% over the past ten years .